Wells A Messersmith

6PUBLICATIONS
65CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Aged care nursingCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Aug 06, 2024
A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Andrew L Coveler, Matthew J Reilley, Mark Zalupski

|Jul 24, 2024
Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer.

Jacob B Leary, Junxiao Hu, Alexis Leal

|Jun 13, 2024
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.

Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford

|Jun 10, 2024
Respect for the Patient-Oncologist Relationship May Limit Serious Illness Communication by Acute and Postacute Care Clinicians After Discharge to a Skilled Nursing Facility.

Sarguni Singh, Ashley Dafoe, John Cagle

|Sep 29, 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment.

Jesus Amo-Aparicio, Adrian Dominguez, Shaikh M Atif

Pageof 1

Frequent Collaborators

4 joint publications

Christopher H Lieu

4 joint publications

Robert W Lentz

3 joint publications

Adrian T A Dominguez

3 joint publications

Sunnie S Kim